1184 related articles for article (PubMed ID: 27506424)
1. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
3. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
[TBL] [Abstract][Full Text] [Related]
4. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
5. A flexible-dose dispenser for immediate and extended release 3D printed tablets.
Pietrzak K; Isreb A; Alhnan MA
Eur J Pharm Biopharm; 2015 Oct; 96():380-7. PubMed ID: 26277660
[TBL] [Abstract][Full Text] [Related]
6. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
7. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
8. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
9. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
11. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
12. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion.
Bhatt U; Malakar TK; Murty US; Banerjee S
Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.
Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW
Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468
[TBL] [Abstract][Full Text] [Related]
14. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
[TBL] [Abstract][Full Text] [Related]
15. Immediate Release 3D-Printed Tablets Produced Via Fused Deposition Modeling of a Thermo-Sensitive Drug.
Kempin W; Domsta V; Grathoff G; Brecht I; Semmling B; Tillmann S; Weitschies W; Seidlitz A
Pharm Res; 2018 Apr; 35(6):124. PubMed ID: 29679157
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
Zhang P; Xu P; Chung S; Bandari S; Repka MA
Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
[TBL] [Abstract][Full Text] [Related]
17. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
18. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and
Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
[TBL] [Abstract][Full Text] [Related]
20. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
